0000000000402446
AUTHOR
John O'donoghue
showing 4 related works from this author
Towards Improved Healthcare Performance: Examining Technological Possibilities and Patient Satisfaction with Wireless Body Area Networks
2009
Published version of an article from the journal: Journal of Medical Systems. he original publication is available at Springerlink. http://dx.doi.org/10.1007/s10916-009-9291-8 This paper investigates the benefits of using less intrusive wireless technologies for heart monitoring. By replacing well established heart monitoring devices (i.e. Holter) with wireless ECG based Body Area Networks (BAN), improved healthcare performance can be achieved, reflected in (1) high quality ECG recordings during physical activities and (2) increased patient satisfaction. A small scale clinical trial was conducted to compare both technologies and the results illustrate that the wireless ECG monitor was able …
Design Requirements for a Patient Administered Personal Electronic Health Record
2011
Published version of a chapter in the book: Biomedical engineering, trends in electronics, communications and software. Intech, 2011 Open Access
Introduction to the 5th International Workshop on Intelligent Environments Supporting Healthcare and Well-Being (WISHWell13)
2013
This workshop is designed to bring together researchers from both industry and academia from the various disciplines to discuss how innovation in the use of technologies to support healthier lifestyles can be moved forward. There has been a growing interest around the world and especially in Europe, on investigating the potential consequences of introducing technology to deliver social and health care to citizens (see for example [1]). This implies an important shift on how social and health care are delivered and it has positive as well as negative consequences which must be investigated carefully. On the other hand there is an urgency provided by the changes in demographics which is putti…
Familial hypercholesterolaemia: A global call to arms
2015
Familial Hypercholesterolaemia (FH) is the commonest autosomal co-dominantly inherited condition affecting man. It is caused by mutation in one of three genes, encoding the low-density lipoprotein (LDL) receptor, or the gene for apolipoprotein B (which is the major protein component of the LDL particle), or in the gene coding for PCSK9 (which is involved in the degradation of the LDL-receptor during its cellular recycling). These mutations result in impaired LDL metabolism, leading to life-long elevations in LDL-cholesterol (LDL-C) and development of premature atherosclerotic cardiovascular disease (ASCVD) [1], [2] and [3]. If left untreated, the relative risk of premature coronary artery d…